A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)

NCT02799381 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease (PD)

Interventions

DRUG: Optimized antiparkinsonian treatment
DRUG: Levodopa-Carbidopa Intestinal Gel (LCIG)
DEVICE: CADD-Legacy ambulatory infusion pump
DEVICE: Percutaneous endoscopic gastrostomy tube
DEVICE: Jejunal extension tube

Sponsor

AbbVie